105 related articles for article (PubMed ID: 8476199)
1. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. II. Synergism with combined chemotherapy action.
De Loecker W; Janssens J; Bonte J; Taper HS
Anticancer Res; 1993; 13(1):103-6. PubMed ID: 8476199
[TBL] [Abstract][Full Text] [Related]
2. Synergistic cytotoxic action of vitamin C and vitamin K3.
Zhang W; Negoro T; Satoh K; Jiang Y; Hashimoto K; Kikuchi H; Nishikawa H; Miyata T; Yamamoto Y; Nakano K; Yasumoto E; Nakayachi T; Mineno K; Satoh T; Sakagami H
Anticancer Res; 2001; 21(5):3439-44. PubMed ID: 11848506
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action.
Noto V; Taper HS; Jiang YH; Janssens J; Bonte J; De Loecker W
Cancer; 1989 Mar; 63(5):901-6. PubMed ID: 2914296
[TBL] [Abstract][Full Text] [Related]
4. The in vitro antitumor activity of vitamins C and K3 against ovarian carcinoma.
von Gruenigen VE; Jamison JM; Gilloteaux J; Lorimer HE; Summers M; Pollard RR; Gwin CA; Summers JL
Anticancer Res; 2003; 23(4):3279-87. PubMed ID: 12926064
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-inducing activity of vitamin C and vitamin K.
Sakagami H; Satoh K; Hakeda Y; Kumegawa M
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):129-43. PubMed ID: 10726979
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of the antiproliferative effect of vitamin K3 on Jurkat cells.
Kovalenko DV; Zelenin AV
Biochemistry (Mosc); 1999 Apr; 64(4):468-72. PubMed ID: 10231603
[TBL] [Abstract][Full Text] [Related]
7. [Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro].
Li J; Hui N; Zhu L
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):429-31. PubMed ID: 8697994
[TBL] [Abstract][Full Text] [Related]
8. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antitumour activity of vitamins C and K3 against human prostate carcinoma cell lines.
Venugopal M; Jamison JM; Gilloteaux J; Koch JA; Summers M; Hoke J; Sowick C; Summers JL
Cell Biol Int; 1996 Dec; 20(12):787-97. PubMed ID: 9032939
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K3 inhibition of malignant murine cell growth and human tumor colony formation.
Chlebowski RT; Dietrich M; Akman S; Block JB
Cancer Treat Rep; 1985 May; 69(5):527-32. PubMed ID: 4005875
[TBL] [Abstract][Full Text] [Related]
11. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer.
Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK
Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417
[TBL] [Abstract][Full Text] [Related]
12. Non-toxic sensitization of cancer chemotherapy by combined vitamin C and K3 pretreatment in a mouse tumor resistant to oncovin.
Taper HS; Roberfroid M
Anticancer Res; 1992; 12(5):1651-4. PubMed ID: 1444232
[TBL] [Abstract][Full Text] [Related]
13. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
[TBL] [Abstract][Full Text] [Related]
14. Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells.
Liao WC; Wu FY; Wu CW
Int J Oncol; 2000 Aug; 17(2):323-8. PubMed ID: 10891542
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin C on androgen independent prostate cancer cells (PC3 and Mat-Ly-Lu) in vitro: involvement of reactive oxygen species-effect on cell number, viability and DNA synthesis.
Menon M; Maramag C; Malhotra RK; Seethalakshmi L
Cancer Biochem Biophys; 1998 Jun; 16(1-2):17-30. PubMed ID: 9923964
[TBL] [Abstract][Full Text] [Related]
16. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
17. Combination effect of lignin F and natural products.
Jiang Y; Satoh K; Aratsu C; Kobayashi N; Unten S; Kakuta H; Kikuchi H; Nishikawa H; Ochiai K; Sakagami H
Anticancer Res; 2001; 21(2A):965-70. PubMed ID: 11396189
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins.
Osada S; Osada K; Carr BI
J Mol Biol; 2001 Dec; 314(4):765-72. PubMed ID: 11733995
[TBL] [Abstract][Full Text] [Related]
20. Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines.
Wigington DP; Urben CM; Strugnell SA; Knutson JC
Anticancer Res; 2004; 24(5A):2905-12. PubMed ID: 15517895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
